X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0%
Tue, 23 Oct

ALEMBIC PHARMA has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:

ALEMBIC PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-17*
3
Jun-18*
3
Sep-18*
QoQ ChangeYoY Change
Net SalesRs m7,8938,62511,27130.7%42.8%
Other incomeRs m771242270.0%-69.1%
TurnoverRs m7,9708,62611,29430.9%41.7%
ExpensesRs m6,1017,1158,24715.9%35.2%
Gross profitRs m1,7911,5103,023100.2%68.8%
DepreciationRs m2572762863.7%11.6%
InterestRs m41658270.1%1560.0%
Profit before taxRs m1,6081,2202,703121.6%68.1%
TaxRs m366315703122.9%92.2%
Profit after taxRs m1,2429042,000121.2%61.0%
Gross profit margin%22.717.526.8
Effective tax rate%22.725.926.0
Net profit margin%15.610.517.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 42.8% on a year-on-year (YoY) basis. The expenses were up by 35.2% YoY during the same period.
  • The company's operating profit increased by 68.8% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 26.8% in 2QFY19 as against 22.7% in 2QFY18.
  • Depreciation charges and finance costs increased by 11.6% YoY and 1560.0% YoY, respectively.
  • Other income declined by 69.1% YoY during the quarter.
  • Net profit for the quarter increased by 61.0% YoY. Net profit margins during the quarter increased from 15.6% in 2QFY18 to 17.7% in 2QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 30.7% on a quarter-on-quarter (QoQ) basis. The expenses were up by 15.9% QoQ during the same period.
  • The company's operating profit increased by 100.2% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 26.8% in 2QFY19 as against 17.5% in 1QFY18.
  • Net profit for the quarter increased by 121.2% QoQ, while net profit margins increased from 10.5% in 1QFY18 to 17.7% in 2QFY19.

To see how ALEMBIC PHARMA has performed over the last eight quarters, please visit here.

ALEMBIC PHARMA Share Price Performance

Over the last one year, ALEMBIC PHARMA share price has moved up from Rs 496.0 to Rs 575.0, registering a Gain of Rs 79.1 or around 15.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,438.9 (down 0.5%). Over the last one year it has moved up from 14,047.3 to 14,438.9, a gain of 392 points (up 2.8%).

Overall, the S&P BSE SENSEX is up 4.6% over the year.

Current Valuations

At the current price of Rs 575.0, the price to earnings (P/E) ratio of ALEMBIC PHARMA stands at 20.7 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 4.9 times.

Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0%". Click here!

  

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 42.6% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, ALEMBIC PHARMA has posted a net profit of Rs 904 m (up 42.6% YoY). Sales on the other hand came in at Rs 9 bn (up 33.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

My Top 7 Stocks to Buy as Modi Returns to Power(The 5 Minute Wrapup)

May 23, 2019

The Modi government is all set to come back to power. With a stable government at the centre, how should you play the stock market?

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


May 27, 2019 10:47 AM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS